Who owns Pds Biotechnology Ord?
- Ticker: PDSB
- CUSIP Number: 70465t107
Tip: Access positions for across all investors
Analyze quarterly positions in Pds Biotechnology Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Pds Biotechnology Ord stock
Who bought or sold Pds Biotechnology Ord this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
---|---|---|---|---|---|
Vanguard Group | 1.5M | $2.5M | -1% | Dec 2024 |
|
BlackRock | 523k | $853k | 7% | Dec 2024 |
|
Geode Capital Management | 417k | $680k | 1% | Dec 2024 |
|
Susquehanna International | 275k | $447k | 60% | Dec 2024 |
|
Citadel Advisors | 235k | $383k | 93% | Dec 2024 |
|
William Blair $ Company | 158k | $257k | 29% | Dec 2024 |
|
State Street Corporation | 133k | $217k | 19% | Dec 2024 |
|
Millennium Management | 126k | $206k | -46% | Dec 2024 |
|
HAP Trading | 107k | $3.8k | -30% | Dec 2024 |
|
Renaissance Technologies | 100k | $163k | 331% | Dec 2024 |
|
Northern Trust | 83k | $135k | -11% | Dec 2024 |
|
Commonwealth Equity Services | 78k | $127k | -1% | Dec 2024 |
|
Integrys Wealth Advisors | 75k | $90k | 3% | Mar 2025 |
|
Two Sigma Investments | 66k | $107k | 273% | Dec 2024 |
|
Virtu Financial | 55k | $89k | 100% | Dec 2024 |
|
UBS Group | 50k | $82k | 147% | Dec 2024 |
|
Vontobel Holding | 40k | $65k | 0% | Dec 2024 |
|
Marshall Wace | 39k | $64k | 38% | Dec 2024 |
|
Jane Street | 36k | $58k | 100% | Dec 2024 |
|
Bank of New York Mellon | 29k | $48k | 0% | Dec 2024 |
|
Caption Management | 27k | $45k | -79% | Dec 2024 |
|
Bank of America Corporation | 27k | $44k | 0% | Dec 2024 |
|
T. Rowe Price Associates | 25k | $41k | 0% | Dec 2024 |
|
XTX Topco | 25k | $40k | -63% | Dec 2024 |
|
Tempus Wealth Planning | 19k | $31k | 0% | Dec 2024 |
|
Dimensional Fund Advisors | 18k | $30k | -27% | Dec 2024 |
|
Morgan Stanley | 18k | $29k | -35% | Dec 2024 |
|
Raymond James Financial | 16k | $26k | 100% | Dec 2024 |
|
Wealth Group | 15k | $25k | 0% | Dec 2024 |
|
Sherbrooke Park Advisers | 14k | $23k | -65% | Dec 2024 |
|
Federation des caisses Desjardins du Quebec | 14k | $23k | 53% | Dec 2024 |
|
Sandbox Financial Partners | 13k | $15k | 100% | Mar 2025 |
|
Mercer Global Advisors | 13k | $20k | 0% | Dec 2024 |
|
J.W. Burns & Company | 10k | $12k | 0% | Mar 2025 |
|
Simplex Trading | 8.3k | $13k | 23% | Dec 2024 |
|
Kathleen S. Wright Associates | 7.0k | $11k | 0% | Dec 2024 |
|
Tower Research Capital | 5.1k | $8.2k | 82% | Dec 2024 |
|
Advisor Group Holdings | 5.0k | $19k | -5% | Dec 2024 |
|
Wells Fargo & Company | 4.8k | $7.9k | 2% | Dec 2024 |
|
Ronald Blue Trust | 4.5k | $7.3k | 0% | Dec 2024 |
|
Creative Financial Designs | 3.0k | $4.9k | 46% | Dec 2024 |
|
WR Wealth Planners | 2.0k | $3.3k | 0% | Dec 2024 |
|
Royal Bank of Canada | 1.5k | $2.0k | -43% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 1.2k | $2.0k | -3% | Dec 2024 |
|
Bessemer | 1.1k | $2.0k | 100% | Dec 2024 |
|
Truvestments Capital | 1.1k | $1.8k | 0% | Dec 2024 |
|
FMR | 847.00 | $1.4k | -62% | Dec 2024 |
|
Jpmorgan Chase & Co | 619.00 | $1.0k | 0% | Dec 2024 |
|
EverSource Wealth Advisors | 431.00 | $703.004100 | 155% | Dec 2024 |
|
SBI Securities | 106.00 | $173.002600 | 100% | Dec 2024 |
|
Citigroup | 20.00 | $33.000000 | -9% | Dec 2024 |
|
National Bank Of Canada /fi/ | 1.00 | $2.000000 | 0% | Dec 2024 |
|
Who sold out of Pds Biotechnology Ord?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
---|---|---|---|
Amussen Hunsaker & Associates | Sep 2024 | 75k | $287k |
Point72 Asia | Sep 2024 | 22k | $86k |
Cubist Systematic Strategies | Sep 2024 | 18k | $70k |
Qube Research & Technologies | Sep 2024 | 16k | $60k |
Invesco | Sep 2024 | 14k | $53k |
Charles Schwab Investment Management | Sep 2024 | 13k | $51k |
Lazari Capital Management | Sep 2024 | 13k | $50k |
LPL Financial | Sep 2024 | 10k | $40k |
Point72 | Sep 2024 | 50.00 | $191.000000 |
NISA Investment Advisors | Sep 2024 | 18.00 | $68.999400 |